Related Experiment Videos
Phosphoinositide 3-kinase inhibition in cancer treatment
1Department of Cell Biology and Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mrio Negri Sud, Santa Maria Imbaro, Chieti, Italy. berrie@dcbo.cmns.mnegri.it
Abstract:
Over the past ten years, our knowledge of the integral role that the phospho-inositide 3-kinases (PI3Ks) and their 3'-phosphorylated lipid products (3'-phosphorylated phosphoinositides; 3P-PIs) play in the mediation of signal transduction, cytoskeletal rearrangements and membrane trafficking has expanded considerably. They are now known to be involved in the regulation of cell growth, differentiation, mobility, proliferation and survival and hence they have become a potential target for the control of the growth and spread of cancer cells. More recently, the correlation of the multiplicity of isomers (both catalytic and regulatory) within the different classes of the PI3Ks with their functional relevance has become possible. This, combined with our further understanding of the protein recognition patterns for their different 3P-PIs and the newly-described pathways in the control of the levels of these by dephosphorylation, has provided new aspects and areas for interference in these multiple PI3K signalling pathways. However, in the search for effective, non-toxic, drugs for use in the treatment of cancers, these individual targets for PI3K inhibition need to be further correlated with the specific in vivo effects on cell survival, invasivity and metastatic potential. Here, the range of PI3K inhibition targets are discussed in the light of recent experimental findings, with a view to the exploitation of their specificities in new approaches to effective cancer treatments based on PI3K activity inhibition.
Insights
Phospho-inositide 3-kinases (PI3Ks) and their products are crucial in cell signaling and cancer growth. Targeting PI3K pathways offers potential for novel, effective cancer treatments by inhibiting these key regulators.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phospho-inositide 3-kinases (PI3Ks) and their 3'-phosphorylated phosphoinositide products (3P-PIs) are integral to signal transduction, cytoskeletal dynamics, and membrane trafficking.
- These pathways regulate fundamental cellular processes including growth, differentiation, mobility, proliferation, and survival, making them significant targets in cancer therapy.
Purpose of the Study:
- To review the range of PI3K inhibition targets in light of recent experimental findings.
- To discuss the exploitation of PI3K pathway specificities for novel cancer treatment approaches.
Main Methods:
- Literature review of recent experimental findings on PI3K signaling.
- Analysis of PI3K isomer multiplicity and functional relevance.
- Investigation of protein recognition patterns for 3P-PIs and dephosphorylation pathways.
Main Results:
- Understanding of PI3K roles in cell regulation has expanded significantly.
- Correlation between PI3K isomers and functional relevance is now possible.
- New insights into pathways controlling 3P-PI levels offer novel interference strategies.
Conclusions:
- Targeting PI3K pathways presents a promising strategy for cancer treatment.
- Further correlation of individual PI3K targets with in vivo effects on cancer progression is necessary.
- Exploiting PI3K pathway specificities can lead to more effective and less toxic cancer therapies.